TELA Bio Inc Ordinary Shares TELA

Morningstar Rating
$0.81 −0.01 (1.62%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TELA is trading at a LOCK|D#jHW premium.
Price
$0.82
Fair Value
LOCK|wt%$mhL
Uncertainty
LOCK|#h <#LN?
1-Star Price
LOCK|&!xV#r
5-Star Price
LOCK|^@?vDC
Economic Moat
LOCK|v?
Capital Allocation
—

Trading Information

Previous Close Price
$0.82
Day Range
$0.76–0.82
52-Week Range
$0.50–1.50
Bid/Ask
$0.80 / $0.81
Shares Outstanding
45.19M
Market Cap
$35.80M
Volume/Avg
37,734 / 227,324

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
0.59
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
218

Valuation

Metric
TELA
Price/Earnings (Normalized)
—
Price/Book Value
—
Price/Sales
0.59
Price/Cash Flow
—
Price/Earnings
TELA

Financial Strength

Metric
TELA
Quick Ratio
0.44
Current Ratio
0.61
Interest Coverage
−4.28
Quick Ratio
TELA

Profitability

Metric
TELA
Return on Assets (Normalized)
−60.64%
Return on Equity (Normalized)
—
Return on Invested Capital (Normalized)
−72.13%
Return on Assets
TELA

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|<<^#!@GLOCK|Lgw&k$188B
Medtronic PLC
MDT
LOCK|!!SG<%LOCK|&TB#$132B
Stryker Corp
SYK
LOCK|BV@cg?&LOCK|W%$118B
Boston Scientific Corp
BSX
LOCK|lrF&mN?LOCK|tl@&^$64B
Edwards Lifesciences Corp
EW
LOCK|@cH$cW^?LOCK|@wv&q$62B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|^L$pfWWLOCK|#y$38B
DexCom Inc
DXCM
LOCK|xH!ScmjLOCK|^TjT$31B
Koninklijke Philips NV ADR
PHG
LOCK|pQLOCK|#$$30B
Steris PLC
STE
LOCK|<qb%p?LOCK|THsx$26B
Zimmer Biomet Holdings Inc
ZBH
LOCK|%q>Nnj@LOCK|$j$$20B

Sponsor Center